Denali Therapeutics Inc.

NASDAQ: DNLI · Real-Time Price · USD
14.15
0.19 (1.36%)
At close: May 15, 2025, 3:59 PM
14.16
0.04%
After-hours: May 15, 2025, 04:14 PM EDT

Denali Therapeutics Revenue

Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
443
Market Cap
2.06B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.